ym 872 has been researched along with Brain Edema in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, K; Sasamata, M; Suzuki, M; Terai, K; Yamaguchi, T; Yatsugi, Si | 1 |
| Asakura, T; Atsumi, T; Furukawa, T; Hoshino, S; Kobayashi, S; Takahashi, M; Teramoto, A | 1 |
| Asakura, T; Atsumi, T; Furukawa, T; Hoshino, S; Kobayashi, S; Takahashi, M; Teramoto, A; Yamamoto, Y | 1 |
3 other study(ies) available for ym 872 and Brain Edema
| Article | Year |
|---|---|
Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model.
Topics: Animals; Atrophy; Brain Edema; Brain Infarction; Cerebral Hemorrhage; Collagenases; Dose-Response Relationship, Drug; Hematoma; Heparin; Imidazoles; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 2003 |
The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats.
Topics: Animals; Body Temperature; Brain Edema; Brain Injuries; Cerebral Cortex; Glutamic Acid; Imidazoles; Male; Models, Animal; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Recovery of Function | 2003 |
The glutamate AMPA receptor antagonist, YM872, attenuates regional cerebral edema and IgG immunoreactivity following experimental brain injury in rats.
Topics: Animals; Body Water; Brain; Brain Edema; Brain Injuries; Imidazoles; Immunoglobulin G; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 2003 |